The Blood Banking Market: Emerging Opportunities And Business Development Strategies: A 7-Country Market Survey

Content

• I. Introduction
• II. Worldwide Technology and Market Overview
  • A. Major Blood Typing, Grouping & Infectious Disease Screening Tests
    • 1. Blood Typing and Grouping Tests
      • a. Abo
      • b. Antibody Panels
      • c. Antibody Screening
      • d. Antigen Typing
      • e. Antiglobulin Test
      • f. Crossmatch
      • g. Hla Typing
      • h. Rh
      • I. Other Blood Groups
    • 2. Infectious Disease Screening Tests
      • a. Aids
        • Structure & Composition
        • Classification
        • Hiv-2 Infection
        • Origin of Aids
        • Animal Lentivirus Systems
        • Virus Receptors
        • Hiv Infections in Humans
          • -Pathogenesis & Pathology
          • -Overview of Infection Course
        • Cd4t Lymphocytes and Memory Cells
        • Monocytes & Macrophages
        • Lymphoid Organs
        • Neural Cells
        • Viral Coinfections
          • -Clinical Findings
        • Plasma Viral Load
        • Pediactric Aids
          • -Neurologic Disease
          • -Opportunistic Infections
          • -Protozoa
          • -Fungi
          • -Bacteria
          • -Viruses
          • -Cancer
        • Immunity
        • Laboratory Diagnosis
          • -Virus Isolation
          • -Serology
          • -Detection of Viral Nucleic Acid Or Antigens
        • Epidemiology
          • -Worldwide Spread
          • -United States
          • -Transmission Routes
        • Prevention, Treatment & Control
          • -Antiviral Drugs
          • -Vaccines
        • Transmission in Blood Products
        • Transmission in Transplant& Artificial Insemination Recipients
        • Diagnostic Tests
          • -Eia Interpretation
          • -Specificity, Sensitivity & Predictive Value
        • Competition Assays
        • Western Blot
        • Ifa
        • Radioimmunoprecipitation
        • Hiv-1 Hiv-2 Combination Testing
        • Methods of Hiv Antigen Detection
        • Antigen Assays & Blood Screening
        • Urine Tests
        • Dna Probes
          • -Overview
          • -Quantitative Pcr
          • -in Situ Pcr
          • -Needed Improvements
        • Viral Load/Drug Resistance Testing
        • Genotype & Phenotype Testing
        • Blood Banking Considerations
      • b. Hepatitis
        • Hepatitis A
        • Hepatitis B
          • -Structure & Composition
          • -Replication
        • Hepatitis C
        • Hepatitis D (Delta)
        • Hepatitis E
        • Hepatitis G
        • Infections in Humans
          • -Pathology
        • Clinical Findings
        • Laboratory Features
          • -Hepatitis A
          • -Hepatitis B
          • -Hepatitis C
          • -Hepatitis D
          • -Hepatitis E
        • Virus-Host Immune Reactions
        • Epidemiology
          • -Hepatitis A
          • -Hepatitis B
          • -Hepatitis C
          • -Hepatitis D (Delta)
        • Vaccines and Drugs
      • c. Cytomegalovirus
        • Background
        • Chorioretinitis
        • Gastrointestinal
        • Central Nervous System
        • Diagnostic Tests
        • Vaccines and Drugs
      • d. Syphilis
        • Background
        • Diagnostic Tests
        • Vaccines and Drugs
      • e. West Nile Virus
        • Background
        • Clinical Syndromes
        • Diagnostic Tests
        • Vaccines and Drugs
      • f. Parvovirus B19
        • Microbiology
        • Epidemiology
        • Clinical Syndromes
          • -Erythema Infectiosum
          • -Adult Polyarthropathy
          • -Transient Aplastic Crisis
          • -Transient Pancytopenia
          • -Red Cell Aplasia in Immunocompromised
          • -Perinatal Infections
        • Diagnosis
        • Treatment
      • g. Creutzfeldt-Jakob's Disease
        • Background
        • Transmission
        • Diagnostic Tests
        • Major Players
          • -Bayer
          • -Disease Sciences/BioTec Global
          • -Imperial College School of Medicine
          • -Ortho-Clinical Diagnostics
          • -Pall
          • -ProMetic Life Sciences
          • -Q-One Biotech
          • -Serono
          • -U S. Agricultural Research
        • Drugs
        • Vaccines
      • h. Malaria
      • I. Chagas Disease
      • j. Babesiosis
    • 3. Pathogen Reduction
    • 4. Leukocyte Reduction
      • a. Background
      • b. Methods
  • B. Instrumentation Review
    • 1. Abbott Prism
    • 3. Abbott Commander
    • 4. BioMeriuex Bact/Alert
    • 5. Dade Behring Quadriga
    • 6. Dade Behring Bep 2000
    • 7. Grifols Diana
    • 8. Immucor ABS2000
    • 9. Immucor Galileo
    • 10. Immucor Rosys Plato
    • 11. Olympus PK7100
    • 12. Olympus PK7200
    • 13. Olympus PK80
    • 14. Olympus BloodTrack Courier
    • 15. Ortho AutoVue
    • 16. Ortho ProVue
    • 17. Ortho Summit Processor
    • 18. Tecan ELPHAtyper
    • 19. Tecan Hemotyper
    • 21. Tecan MiniSwift
  • C. Major in Vitro Diagnostic Technologies and Applications
    • 1. Molecular Diagnostics
      • a. Overview
      • b. Nat
    • 2. Monoclonal and Polyclonal Antibodies
    • 3. Immunoassays
      • a. Technological Principle
      • b. Enzyme Immunoassays
        • Overview
        • Elisa
        • Enzyme Amplification
      • c. Fluorescent Immunoassays
        • Fluorescence Polarization
      • d. Luminescence
        • Chemiluminescence
        • Bioluminescence
      • e. Latex Agglutination
      • f. Immunoprecipitation
    • 4. Microtitration Plates
    • 5. Microcomputers
    • 6. Automation
    • 7. Lasers
    • 8. Robotics
    • 9. Artificial Intelligence
    • 10. Synthetic Red Cell Substitutes
    • 11. Genetically Engineered Blood Components
      • a. Albumin
      • c. Alpha-2 Antiplasmin
      • f. Von Willebrand's Factor
      • g. Fibrinogen
      • h. t-Pa
    • 12. Blood Preservation
    • 13. Autologous Blood Transfusion/Freezing
  • D. Worldwide Market Overview
    • 1. Business Environment
    • 2. Market Structure
    • 3. Market Size and Growth
• III. France
  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Consumable Sales, Instrument Placements, Installed Base and Market Shares
• IV. Germany
  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Consumable Sales, Instrument Placements, Installed Base and Market Shares
• V. Italy
  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Consumable Sales, Instrument Placements, Installed Base and Market Shares
• VI. Japan
  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Consumable Sales, Instrument Placements, Installed Base and Market Shares
• VII. Spain
  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Consumable Sales, Instrument Placements, Installed Base and Market Shares
• VIII. U K.
  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Consumable Sales, Instrument Placements, Installed Base and Market Shares
• IX. U S A.
  • A. Executive Summary
  • B. Business Environment
    • 1. Overview
    • 2. Health Care Expenditures
    • 3 Cost Consciousness
    • 4. Reimbursement
    • 5. Industry Consolidation
    • 6. Managed Care
      • a. Hmo
      • b. Ppo
    • 7. Hospitals
    • 8. Admissions
    • 9. Length of Stay
    • 10. Industry Diversification
    • 11. Physician Demographics
    • 12. Population Aging
      • a. Chronic Illnesses
      • b. Disease Incidence
      • c. Susceptibility to Iatrogenesis
      • d. Multiple Illness Cases
    • 13. Laboratory Regulations
    • 14. FDA Reform
  • C. Market Structure
    • 1. Testing Facilities
      • a. Community and Regional Centers
      • b. Plasma Fractionation Centers
      • c. Hospitals
      • d. Commercial/Private Labs
      • e. Military Blood Banks
      • f. Commercial Blood Banks
    • 2. Collection Facilities
  • D. Market Size, Growth and Major Suppliers' Consumable Sales, Instrument Placements, Installed Base and Market Shares
• X. Major Product Development Opportunities
  • A. Blood Typing and Grouping
  • B. Infectious Disease Screening
  • C. Auxiliary
• XI. Alternative Market Penetration Strategies
  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
• XII. Potential Market Entry Barriers and Risks
  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
• XIII. Competitive Assessments
  • Abbott
  • Biokit
  • Bio-Rad
  • Bioscot
  • Biotest
  • Chiron
  • Dade Behring
  • Diagast
  • Diamed
  • DiaSorin
  • Fujirebio
  • Gen-Probe
  • Gradipore
  • Grifols
  • ImmucorGamma
  • Innogenetics
  • Orchid Biosciences
  • Ortho-Clinical Diagnostics
  • Olympus
  • Proteome Sciences
  • Roche
  • Tecan
• XIV. Appendix: Assumed Currency Exchange Rates
• List of Tables
  • Table Ii-1: Major Companies Developing Or Marketing Blood Typing and Grouping Tests
  • Table Ii-2: Major Companies Developing Or Marketing Hla Typing Tests
  • Table Ii-3: Major Companies Developing Or Marketing Aids Tests
  • Table Ii-4: Major Companies Developing Or Marketing Hepatitis Tests
  • Table Ii-5: Major Companies Developing Or Marketing Cmv Tests
  • Table Ii-6: Major Companies Developing Or Marketing Syphilis Tests
  • Table Ii-7: Major Companies Developing Or Marketing Blood Bank Analyzers
  • Table Ii-8: Worldwide, All Market Segments, Facilities Performing Blood Bank Tests by Country
  • Table Ii-9: Worldwide, All Market Segments, Blood Typing and Grouping Test Volume by Country
  • Table Ii-10: Worldwide, All Market Segments, Infectious Disease Screening Test Volume
  • Table Ii-11: Worldwide, All Market Segments, Blood Typing and Grouping Reagent Market by Country
  • Table Ii-12: Worldwide, All Market Segments, Infectious Disease Reagent Market by Country Executive Summary Table: U S A , Blood Bank Test Volume and Reagent Sales by Test Category
  • Table Ix-1: U S A , Estimated Number of Inpatient and Ambulatory Surgeries
  • Table Ix-2: U S A , Facilities Performing Blood Bank Tests by Market Segment
  • Table Ix-3: U S A , Hospital Laboratories Performing Blood Bank Tests by Bed Size
  • Table Ix-4: U S A , Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume
  • Table Ix-5: U S A , Facilities Collecting Whole Blood and Plasma by Market Segment
  • Table Ix-6: U S A , Whole Blood and Plasma Collections by Market Segment
  • Table Ix-7: U S A , Blood Typing and Grouping Test Volume by Market Segment
  • Table Ix-8: U S A , All Market Segments Blood Typing and Grouping Test Volume
  • Table Ix-9: U S A , Hospital Laboratories Blood Typing and Grouping Test Volume
  • Table Ix-10: U S A , Community and Regional Blood Centers Blood Typing and Grouping Test Volume
  • Table Ix-11: U S A , Commercial/Private Laboratories Blood Typing and Grouping Test Volume
  • Table Ix-12: U S A , Plasma Fractionation Centers Blood Typing and Grouping Test Volume
  • Table Ix-13: U S A , Military Blood Banks Blood Typing and Grouping Test Volume
  • Table Ix-14: U S A , Infectious Disease Screening Test Volume by Market Segment
  • Table Ix-15: U S A , All Market Segments Infectious Disease Screening Test Volume
  • Table Ix-16: U S A , Community and Regional Centers Infectious Disease Screening Test Volume
  • Table Ix-17: U S A , Plasma Fractionation Centers Infectious Disease Screening Test Volume
  • Table Ix-18: U S A , Hospital Blood Banks Infectious Disease Screening Test Volume
  • Table Ix-19: U S A , Military Blood Banks Infectious Disease Screening Test Volume
  • Table Ix-20: U S A , All Market Segments Blood Typing and Grouping Reagent Market by Market Segment
  • Table Ix-21: U S A , Blood Typing and Grouping Reagent Market by Market Segment
  • Table Ix-22: U S A , Hospital Blood Banks Blood Typing and Grouping Reagent Market by Major Test
  • Table Ix-23: U S A , Community and Regional Blood Centers Blood Typing and Grouping Reagent Market by Major Test
  • Table Ix-24: U S A , Commercial/Private Laboratories Blood Typing and Grouping Reagent Market by Major Test
  • Table Ix-25: U S A , Plasma Fractionation Centers Blood Typing and Grouping Reagent Market by Major Test
  • Table Ix-26: U S A , Military Blood Banks Blood Typing and Grouping Reagent Market by Major Test
  • Table Ix-27: U S A , Infectious Disease Screening Reagent Market by Market Segment
  • Table Ix-28: U S A , All Market Segments Infectious Disease Screening Reagent Market by Market Segment
  • Table Ix-29: U S A , Community and Regional Centers Infectious Disease Screening Reagent Market by Test
  • Table Ix-30: U S A , Plasma Fractionation Centers Infectious Disease Screening Reagent Market by Test
  • Table Ix-31: U S A , Hospital Blood Banks Infectious Disease Screening Reagent Market by Test
  • Table Ix-32: U S A , Military Blood Banks Infectious Disease Screening Reagent Market by Test
  • Table Ix-33: U S A , Major Suppliers of Blood Typing and Grouping Reagents, Estimated Sales and Market Shares
  • Table Ix-34: U S A , Hiv/Htlv Blood Screening Market by Major Supplier
  • Table Ix-35: U S A , Hepatitis Blood Screening Market by Major Supplier
  • Table Ix-36: U S A , Hepatitis C Blood Screening Market by Major Supplier
  • Table Ix-37: U S A , Hiv/Hepatitis C Nat Blood Screening Market by Major Supplier
  • Table Ix-38: U S A , West Nile Virus Nat Blood Screening Market by Major Supplier
  • Table Ix-39: U S A , Cmv Blood Screening Market by Major Supplier
  • Table Ix-40: U S A , Syphilis Blood Screening Market by Major Supplier
  • Table Ix-41: U S A. Major Suppliers of Blood Bank Automated Analyzers, Estimated Placements and Installed Base